WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) was the recipient of a large growth in short interest in the month of July. As of July 15th, there was short interest totaling 255,103 shares, a growth of 118.2% from the June 30th total of 116,931 shares. Based on an average daily volume of 144,071 shares, the days-to-cover ratio is currently 1.8 days. Approximately 0.0% of the company’s stock are short sold.
WuXi Biologics (Cayman) Stock Performance
Shares of WuXi Biologics (Cayman) stock opened at $9.80 on Tuesday. The stock’s 50-day moving average is $8.72 and its 200-day moving average is $9.09. WuXi Biologics has a one year low of $7.27 and a one year high of $11.21.
About WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.
The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.
Featured Stories
- Five stocks we like better than WuXi Biologics (Cayman)
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
